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Keratinocytes synthesize and secrete urokinase-type
plasminogen activator, which binds to its specific
receptor on keratinocytes. When bound to urokinase-
type plasminogen activator receptor, urokinase-type
plasminogen activator proteolytically converts surface
bound plasminogen to plasmin, which in turn cleaves
many extracellular components leading to pericellular
proteolysis. The activation of the urokinase system has
been observed during re-epithelialization of skin
wounds and in lesions of the autoimmune blistering
skin disease pemphigus. As pemphigus is photo-
inducible, we investigated the effect of ultraviolet B on
urokinase-type plasminogen activator and urokinase-
type plasminogen activator receptor expression in
the epidermal keratinocyte cell line A431. Ultraviolet
B increased cellular and secreted urokinase-type
plasminogen activator protein (enzyme-linked
immunosorbent assay) and urokinase-type plasmino-
gen activator receptor cell surface expression (flow
cytometry) 24 h postirradiation. Northern blot analysis
indicated that ultraviolet B increased urokinase-type
plasminogen activator receptor mRNA. Compared
with a more rapid mRNA induction by epidermal
Keratinocytes synthesize and secrete the urokinase-type plasminogen activator (uPA), which binds to itsspecific receptor (uPAR) on the keratinocyte surface(Kramer et al, 1995). There uPA proteolyticallyactivates cell surface bound plasminogen, which in
turn cleaves many extracellular matrix components providing
pericellular proteolysis. uPA activity is controlled by specific
plasminogen activator inhibitor (PAI) proteins. Activation of the
uPA/plasminogen proteolytic system plays a central role for extra-
cellular matrix degradation under various physiologic and pathologic
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growth factor (maximal after 4 h) the ultraviolet B
response was maximal after 24 h and prolonged up
to 36 h. The mRNA induction was not dependent on
protein synthesis as judged by cycloheximide incuba-
tion. Ultraviolet B did not influence urokinase-type
plasminogen activator receptor mRNA stability (actin-
omycin D incubation). A transiently transfected chlor-
amphenicol acetyltransferase-reporter construct
containing a –398/F51 urokinase-type plasminogen
activator receptor promoter fragment was activated
when cells were exposed to ultraviolet B. This induc-
tion was almost completely abolished by mutating
a –182/–176 AP-1 binding sequence. Ultraviolet B
increased the binding capacity at this AP-1 motif
in electrophoretic mobility shift assays. These data
identify a distinct transcriptional mechanism by which
ultraviolet B induces urokinase-type plasminogen
activator receptor. The epidermal induction of com-
ponents of the proteolytic urokinase system by ultra-
violet B may help explain the photoinducibility of
pemphigus lesions. Key words: keratinocyte/pemphigus/
photobiology/ultraviolet radiation/urokinase-type plasmino-
gen activator receptor. J Invest Dermatol 113:69–76, 1999
conditions, including cancer invasion and cutaneous wound healing
(Kramer et al, 1995; Schmitt et al, 1995; Blasi, 1997).
Pemphigus vulgaris and pemphigus foliaceus are autoimmune
blistering diseases of the skin and mucous membranes. They are
caused by autoantibodies that specifically bind to the desmosomal
proteins desmoglein-3 (pemphigus vulgaris) or desmoglein 1
(pemphigus foliaceus) eventually leading to loss of cell–cell adhesion
(acantholysis) and epidermal blisters (reviewed in Amagai, 1996;
Koch et al, 1997). One additional pathophysiologic mechanism
that may – subsequent to the binding of autoantibodies – contribute
to acantholysis and blister formation is the activation of proteases,
especially of the uPA/plasminogen system. This view is supported
by several observations: uPA and uPAR were detected immuno-
histologically in acantholytic epidermis of pemphigus vulgaris
patients, but not in skin from healthy donors (Schaefer et al, 1996).
In cultured keratinocytes, IgG fractions of sera from patients with
pemphigus vulgaris induced expression of uPA (Wilkinson et al,
1989) and uPAR (Seishima et al, 1997). Pemphigus IgG or
plasminogen-induced acantholysis in skin organ cultures was
inhibited by anti-uPA antibody (Morioka et al, 1987), anti-uPAR
antibody (Xue et al, 1998), purified PAI-2 (Hashimoto et al, 1989),
70 MARSCHALL ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
or synthetic proteinase inhibitors (Naito et al, 1989). Plasmin appears
to be the active enzyme in producing acantholysis (Hashimoto et al,
1983).
Pemphigus lesions, especially in pemphigus foliaceus, can be
induced by solar irradiation or ultraviolet (UV) B irradiation from
artificial radiation sources (Cram, 1965; Jacobs, 1965; Cram and
Fukuyama, 1972; Muramatsu et al, 1996). The pathophysiologic
mechanisms responsible for photosensitivity are not known. In
this report we demonstrate that uPA and uPAR are induced by
UVB in the keratinocyte cell line A431 and that uPA induction is
transcriptionally mediated involving an AP-1 binding site. We
suggest that increased epidermal uPA and uPAR expression may
contribute – via increased pericellular proteolysis – to the acantho-
lysis observed in UV-induced pemphigus lesions.
MATERIALS AND METHODS
Cell culture and reagents The human epidermal cancer cell line A431
was from American Type Culture Collection (Rockville, MD). Cells were
cultured in Dulbecco’s modified Eagle’s medium supplemented with 2 mM
L-glutamine, 100 U penicillin per ml, 100 µg streptomycin per ml, 1 µg
amphotericin B per ml (all from Gibco/BRL, Eggenstein, Germany), and
10% heat-inactivated fetal bovine serum (ccpro, Neustadt, Germany), at
37°C and 5% CO2. Cells were used for experiments at subconfluency. In
some experiments, epidermal growth factor (EGF; pharma biotechnologie,
Berlin, Germany), the phorbol ester phorbol-12-myristate-13-acetate
(PMA), cycloheximide, or actinomycin D (all from Sigma, Deisenhofen,
Germany) were used as indicated.
UVB treatment Immediately prior to irradiation, culture medium was
replaced by phosphate-buffered saline. UVB irradiation was delivered using
a bank of 10 Philips TL 20 W/12 bulbs, which emit most of their energy
within the UVB range with emission peaks at 300–315 nm (Van Weelden
et al, 1988). The energy output measured by a UV meter (Waldmann,
Villingen-Schwenningen, Germany) was 2 mW per cm2 at a source-to
target distance of 37 cm. Irradiation times were calculated for the desired
range of UVB dosages. Immediately after irradiation, cells were provided
with fresh serum-free medium and further incubated at 37°C and 5% CO2
for varying time periods. Unirradiated controls were processed in parallel
and removed from the incubator during irradiation procedures, but kept
from UV exposure.
Assessment of cell viability Cell viability was assessed 24 h and 48 h
after UVB by measurement of lactate dehydrogenase release using the
Cytotoxicity Detection Kit (Boehringer Mannheim, Mannheim, Germany)
according to the manufacturer’s instructions. Various UVB doses up to
45 mJ per cm2 were tested. The highest dose that did not result in an
increase of cytotoxicity after 48 h (15 mJ per cm2) was applied in all
further experiments. At similar UVB doses profound biologic effects like
activation of transcription factors (Simon et al, 1994) or induction of
cytokine synthesis (Kirnbauer et al, 1991) have been documented in
keratinocytes.
Enzyme-linked immunosorbent assay (ELISA) for uPA and
uPAR Cells were seeded in six-well plates and used at subconfluency
after incubation with serum-free medium for 12 h. Cells were either left
untreated or UVB irradiated. Supernatants were collected 24 h post-
irradiation and cleared from cell debris by centrifugation. Adherent cells
were washed with phosphate-buffered saline, extracted with 500 µl of
TBS/Triton (50 mM Tris pH 7.5; 150 mM NaCl; 1% TritonX-100) for
150 min, and cell debris removed by centrifugation. Supernatants and
extracts were stored at –80°C until analysis. UPA and uPAR concentrations
in supernatants and cell extracts were determined using the Immunobind
821 (uPA) and Immunobind 822 (uPAR) ELISA kits (American Diagnostica,
Greenwich, CT) as previously described (Schmalfeldt et al, 1995). The
obtained data were subjected to computer-assisted analysis (EIA program;
ICN-Flow Laboratories, Meckenheim, Germany). Protein concentrations
were determined using the BCA Protein Assay Reagent Kit (Pierce,
Rockford, IL).
Flow cytometry uPAR cell surface expression was assessed by an indirect
two-step staining procedure and subsequent fluorescence-activated cell
sorter analysis. Cells were detached by incubation with phosphate-buffered
saline containing 0.2% ethylenediamine tetraacetic acid. In a first step cells
were either incubated with the murine anti-human uPAR monoclonal
antibody HD-uPAR 13.1 (Todd et al, 1997) or with an isotype-matched
control monoclonal antibody (mouse IgG1, Dianova, Hamburg, Germany).
In a second step, cells were incubated with a FITC-coupled goat anti-
mouse IgG monoclonal antibody (Southern Biotechnologies, Vienna,
Austria). Subsequently, cells were analyzed in a FACScan II flow cytometer
using the Cell Quest analysis program (Becton Dickinson, Heidelberg,
Germany).
Isolation of mRNA and northern blot analysis Cells were seeded in
six-well plates and used for experiments at subconfluency and after
incubation with serum-free medium for a minimum of 6 h. Total cellular
RNA was isolated using the RNA-Clean kit (AGS, Heidelberg, Germany).
The RNA was size-fractionated by formaldehyde/agarose gel electro-
phoresis and blotted to nylon membranes. The blots were dried and RNA
was fixed via UV cross-linking as previously described (Sambrook et al,
1989). A 1.1 kb XbaI–EcoRI fragment of a uPAR cDNA (Roldan et al, 1990)
was radiolabeled with 32P-dATP (Hartmann, Braunschweig, Germany) via
random hexamer primer extension and used as hybridization probe. As a
control for loading uniformity, blots were also hybridized with a [γ32P]-
dATP end-labeled oligodeoxynucleotide (59 CGCCCGCCGCAGCTG-
GGGCGATCC) complementary to the human 28S ribosomal RNA
(Gonzalez et al, 1985). Prehybridization and hybridization were carried out
at 42°C in 50% formamide, 1 M NaCl, 10% dextran, 1% sodium dodecyl
sulfate, 100 µg yeast tRNA per ml and 10 mg salmon sperm DNA per
ml. After overnight hybridization the membranes were washed with 1 3
sodium citrate/chloride buffer containing 0.1% sodium dodecyl sulfate at
increasing temperatures (42–60°C). Autoradiography was performed using
Kodak Biomax MS-1 film with one intensifying screen at –70°C. Specific
signals on autoradiographs were densitometrically quantitated using a CS-1
scanner (Cybertech, Berlin, Germany) and WinCam software (Cybertech).
UPAR-specific signals were normalized to the respective 28S rRNA signals.
Different exposure times were used to ensure that the signal strength of
the analyzed bands on the autoradiographs was in the linear range.
uPAR reporter gene constructs and transient trans-
fections Chloramphenicol acetyltransferase (CAT) expression vectors
containing various portions of the uPAR promoter have been described
previously (Lengyel et al, 1996). Briefly, uPAR 59 fragments were cloned
into pCAT-Promoter (Promega, Madison, WI), from which the SV40
promoter had been removed via XbaI digestion. The CAT expression
vectors are designated by the most 59 nucleotide position of their uPAR
inserts numbered relative to the transcription start site identified 52 bp 59
of the translation start codon (Soravia et al, 1995). In the –398∆AP-1
construct, an AP-1 binding sequence at positions –182/–176 (59 TGAGT-
CA) is mutated to 59 TatcTCA. A promoterless CAT vector (pSV0-CAT)
generated by eliminating the uPAR promoter insert via XbaI-digestion and
re-ligation served as a negative control.
Subconfluent cells grown in 30 mm culture dishes were supplied with
serum-free medium and 3 h later transfected with 3 µg of uPAR-CAT
vector and 3 µg of a β-galactosidase expression vector (pSV β-Galactosidase,
Promega) by calcium phosphate precipitation as previously described
(Degitz et al, 1991). After 16 h cells were washed and incubated with
serum-free medium for 2 h. Subsequently, cells were UVB-irradiated and
lysed 24 h postirradiation.
Cell lysis was performed with Reporter Lysis Buffer (Promega). Lysates
were assayed for β-galactosidase activity using the Beta-Galactosidase
Enzyme Assay System (Promega) as a control for transfection efficiency
among various plates and uPAR-CAT constructs. As a function of uPAR
promoter activity, CAT concentration of cell lysates was determined using
the CAT ELISA Kit (Boehringer Mannheim). In additional experiments
CAT enzyme activity was assayed using 14C-chloramphenicol as a substrate
(New England Nuclear, Bad Homburg, Germany) as described previously
(Degitz et al, 1991). The reaction mixture was extracted with ethyl acetate.
Acetylated and nonacetylated forms of chloramphenicol were resolved by
thin-layer chromatography and visualized by autoradiography (exposure to
a Kodak Biomax MS-1 film at room temperature overnight).
Preparation of nuclear extracts and electrophoretic mobility shift
assays Subconfluent A431 cells were kept in serum-free medium 24 h
prior to lysis and were UVB-irradiated at various time-points before
extraction. Control cells were left untreated, but one control population
was removed from the incubator at each irradiation time-point for the
time of the irradiation procedure. Nuclear extracts were prepared as
previously described (Ausubel et al, 1989). Protein content of extracts was
quantitated photometrically using the Bio-Rad protein assay kit (Bio-Rad,
Mu¨nchen, Germany). Extracts were normalized for protein concentration
prior to analysis.
Nuclear extracts were reacted with a digoxigenin-labeled double-
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Table I. UVB induces uPA and uPAR expression in
A431 cellsa
Control UVBb PMAc
uPA Extract 13.4 6 2.0a 26.8 6 3.0 38.96 6 2.6
Supernatant 11.0 6 3.1 16.7 6 1.8 110.2 6 20.4
uPAR Extract 2.64 6 0.8 6.85 6 2.3 16.87 6 6.3
aUPA and uPAR concentrations of cell extracts and supernatants were measured
by ELISA as described in Materials and Methods. Values are expressed as ng per
mg protein and represent mean 6 SD of three independent experiments.
bMeasurements 24 h after a single UVB-dose of 15 mJ per cm2.
cMeasurements after incubation with 100 ng per ml PMA for 24 h.
stranded oligodeoxyribonucleotide probe representing uPAR promoter
positions –197/–168 relative to the transcription start site and containing
the AP-1 binding motif at positions –182/–176 (top strand: 59-GTGAT-
CACAACTCCATGAGTCAGGGCCGAT, AP-1 binding motif under-
lined). The oligodeoxynucleotide was labeled with digoxigenin using the
DIG Gel Shift Kit (Boehringer Mannheim). For competition studies,
the same double-stranded oligodeoxynucleotide was added unlabeled
to reactions. Another double-stranded oligodeoxynucleotide used for
competition contained the same –197/–168 uPAR promoter fragment as
the probe, however, with a mutated –182/–176 AP-1 binding site (top
strand: 59-GTGATCACAACTCCAccAGTtgGGGCCGAT, AP-1 binding
motif underlined, mutated positions in small letters) (Lengyel et al, 1996).
Additional double-stranded oligodeoxynucleotides contained a consensus-
binding sequence for AP-1 (top strand 59 CGCTTGATGAGT-
CAGCCGGAA, binding sequence underlined; Promega); an AP-1 binding
sequence representing positions –1885/–1879 of the uPA promoter (Nerlov
et al, 1991) (top strand 59 TTGGGAGCAACATGAATCATGACGCGC,
binding sequence underlined); or a consensus-binding sequence for SP1
(top strand 59 ATTCGATCGGGGCGGGGCGAGC, binding motif under-
lined; Promega). Incubation was carried out for 20 min at 21°C in a 20 µl
reaction containing 0.225 mg bovine serum albumin (Sigma) per ml, 0.2 mg
poly dI/dC (Pharmacia, Freiburg, Germany) per ml, 10 mM HEPES, 4 mM
Tris (pH 7.9), 50 mM KCl, 0.5 mM ethylenediamine tetraacetic acid, 0.5 mM
dithiothreitol, 8% (wt/vol) glycerol. DNA–protein binding complexes were
resolved by electrophoresis on nondenaturing 6% polyacrylamide gels in a
0.5 3 TBE (5% glycine wt/vol) running buffer. Gels were run at 12 V per
cm for 2 h, blotted on to nylon membranes (Sambrook et al, 1989), and UV
cross-linked. Chemoluminescent detection was performed as described for
the DIG Gel Shift Kit.
RESULTS
UVB induces uPA and uPAR expression In order to investi-
gate the influence of UVB on components of the uPA/plasminogen
system in a keratinocyte context, expression of uPA and uPAR
proteins was determined in A431 cells by ELISA. UVB (15 mJ per
cm2) increased both cell associated uPA and uPA content of
supernatants 24 h postirradiation (Table I) in accordance with
similar observations after UVC stimulation of human fetal fibroblasts
(Rotem et al, 1987). UVB irradiation also increased uPAR concen-
tration more than 2-fold in extracts of irradiated cells. In supernatants
of both untreated and UVB-irradiated cells uPAR concentrations
were below detection limit (,1 ng per mg protein, data not
shown). PMA, a potent inducer of uPA (Kessler and Markus, 1991)
and uPAR (Lund et al, 1991b), was used as a positive control
stimulus and strongly induced uPA and uPAR after incubation for
24 h (Table I).
A crucial event during pericellular proteolysis mediated by the
urokinase system is the binding of uPA to its cell surface receptor
uPAR. Thus, for further characterization of uPAR induction by
UVB, uPAR cell surface expression was analyzed in fluorescence-
activated cell sorter experiments (Fig 1). A431 cells displayed a
low baseline uPAR expression both in subconfluent (Fig 1) and
confluent cultures (data not shown). The low baseline uPAR
expression was only slightly reduced after prolonged incubation
periods in serum-free medium (data not shown). uPAR expression
was elevated 24 h after UVB and was further increased 48 h
postirradiation thus showing a delayed increase when compared
with PMA stimulation, which was maximal after 24 h and not
further increased after 48 h (Fig 1).
UVB increases uPAR mRNA levels As an initial step in the
characterization of the molecular mechanisms of uPAR induction
by UVB, cellular mRNA levels were analyzed by northern blot
analysis. UVB irradiation increased uPAR mRNA approximately
5-fold (Fig 2A). The mRNA level slowly increased reaching a
maximum at 24 h postirradiation without a marked decline during
the remaining observation period (up to 36 h postirradiation). In
contrast, incubation with the known uPAR inducer EGF resulted
in a faster and stronger increase of uPAR mRNA levels reaching
a maximum after 4 h and declining again during the observation
period (Fig 2B) as previously described in a different cell type
(Lund et al, 1995). Thus, uPAR mRNA induction by UVB displays
delayed and sustained kinetics in accordance with the comparatively
delayed induction of uPAR surface expression (Fig 1).
The induction of uPAR mRNA by UVB is independent of
protein synthesis To assess whether protein synthesis is necessary
for UVB-mediated induction of uPAR, A431 cells were exposed
to the translational inhibitor cycloheximide (10 µg per ml) either
as the sole treatment or immediately after UVB. Effects on
uPAR mRNA were analyzed by northern blot hybridization and
evaluated densitometrically 24 h postirradiation, the time point of
maximal UVB induction of uPAR mRNA. Cycloheximide resulted
in a 2-fold increase of uPAR mRNA (Fig 3), which represented,
however, a smaller increase than the one produced by UVB
(6.5-fold) (Fig 3). The addition of cycloheximide immediately
after UVB did not suppress induction of uPAR mRNA, as would
be expected if protein synthesis was required for UVB induction
of uPAR. Rather, the combination of the two treatment modalities
synergistically and strongly induced uPAR mRNA (more than
20-fold). These experiments suggest that uPAR induction by UVB
does not require protein synthesis.
uPAR mRNA is regulated at the transcriptional
level Whereas mRNA induction frequently results from tran-
scriptional activation, post-transcriptional mechanisms may also be
relevant. In order to assess the extent of transcriptional and post-
transcriptional regulation of uPAR mRNA levels in response to
UVB, A431 cells were exposed to the transcriptional inhibitor
actinomycin D 12 h post-UVB, a time-point at which UVB has a
marked effect on uPAR mRNA. Cellular RNA was isolated after
various incubation periods. uPAR mRNA levels of UVB-irradiated
cells rapidly decreased after addition of actinomycin D (Fig 4).
Throughout the observation period the continuous decline of
mRNA levels showed kinetics similar to those observed in untreated
controls and in cells treated with EGF, whose induction of uPAR
mRNA has been demonstrated to be primarily transcriptionally
regulated (Lund et al, 1995). In contrast, upon PMA incubation
uPAR mRNA levels were still approximately 2-fold higher com-
pared with controls after a 10 h incubation with actinomycin D
indicating that post-transcriptional mechanisms contribute to uPAR
mRNA induction by PMA as previously suggested (Lund et al,
1995; Shetty et al, 1997). These data do not support the view that
UVB induces uPAR mRNA via post-transcriptional regulation,
but rather suggest that induction is predominantly transcriptionally
mediated.
UVB induces AP-1-dependent uPAR-CAT transcrip-
tion As uPAR induction by UVB appeared to be primarily
transcriptionally regulated, we attempted to identify uPAR pro-
moter segments which mediate transcriptional activation in response
to UVB. A431 cells were transiently transfected with CAT-reporter
constructs containing parts of the uPAR promoter (Fig 5A).
Transfected cells were either left untreated or exposed to 15 mJ
UVB per cm2, lysed 24 h postirradiation and subsequently analyzed
by CAT assays. A reporter construct containing a –398/151 uPAR-
promoter fragment displayed a marked induction of promoter
activity when cells were exposed to UVB (Fig 5B). The activity
of the promoterless control vector pSV0-CAT was below the
detection limit of the CAT assay in extracts from untreated cells
and was not increased by UVB irradiation. When a series of CAT
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Figure 1. UVB induces uPAR cell surface expression. Fluorescence-activated cell sorter analysis of untreated controls and of cells exposed to UVB
(15 mJ per cm2) or PMA (100 ng per ml). Cells were analyzed (A) 24 h or (B) 48 h after UVB irradiation and after 24 h or 48 h of PMA treatment.
Staining was performed with either an anti-uPAR monoclonal antibody (uPAR, solid lines) or an isotype control monoclonal antibody (control, dotted
lines). One representative of three independent experiments is displayed.
Figure 2. UVB increases uPAR mRNA
expression. Total cellular RNA was isol-
ated from UVB irradiated (15 mJ per cm2;
A) or EGF stimulated (10 ng per ml; B)
cells after various time-points. Seventeen
micrograms of total RNA were elec-
trophoresed and analyzed by northern blot
hybridization using a 32P-labeled human
uPAR cDNA probe (upper panel). Hybrid-
ization with a 32P-labeled human 28S
rRNA oligodeoxynucleotide probe is
shown as a control for loading uniformity.
Specific signals on autoradiographic films
were densitometrically quantitated as
described in Materials and Methods (lower
panel). The UVB data are representative of
three independent experiments.
plasmids carrying 59 deletional mutants of the uPAR promoter
were tested (Fig 5C), constructs containing fragments –398/151
and –205/151 displayed a marked increase in promoter activity
when cells were exposed to UVB. A strong reduction of induci-
bility was observed in the shorter –162/151 construct, however,
indicating that uPAR sequences between positions –205 and –162
were most relevant for UVB inducibility of the uPAR promoter.
Furthermore, mutation of the –182/–176 AP-1 binding site
markedly reduced UVB inducibility suggesting an AP-1-dependent
transcriptional regulation.
UVB increases binding of nuclear proteins at the AP-1
sequence in the uPAR promoter In an attempt to confirm
the role of the AP-1 binding sequence for UVB induction
of uPAR transcription, a double-stranded oligodeoxynucleotide
representing uPAR 59 region and containing the –182/–176 AP-1
site was tested against nuclear extracts from untreated or UVB-
irradiated A431 cells in electrophoretic mobility shift assays.
Whereas baseline DNA–protein complexes were formed when
extracts from untreated cells were used, there was a marked
enhancement of complex formation in extracts from UVB-
irradiated cells (Fig 6). Increased binding affinity was noticeable
only at later time-points (extract preparation 6 h and 24 h
postirradiation), whereas an earlier time-point (1.5 h postirradiation)
did not reveal increased binding. The inducible binding complex
was found to be AP-1 specific, because it was competed away by
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Figure 3. UVB induction of uPAR is not dependent on de novo
protein synthesis. Total cellular RNA was isolated from untreated
(control), UVB (15 mJ per cm2) and/or cycloheximide (CHX; 10 µg per
ml) treated cells after 24 h. Seventeen micrograms of total RNA were
electrophoresed and analyzed by northern blot hybridization (upper panel)
using a 32P-labeled human uPAR cDNA probe or a 32P-labeled human
28S rRNA oligodeoxynucleotide probe as a control for loading uniformity.
Specific signals on autoradiographs were densitometrically quantitated as
described in Materials and Methods (lower panel). The data are from one of
two independent experiments with similar results.
a 100-fold excess of either unlabeled identical double-stranded
oligodeoxynucleotide, a double-stranded oligodeoxynucleotide
containing an AP-1 consensus-binding sequence, or an AP-1
binding site derived from the uPA promoter, whereas it remained
unaffected by the presence of a 100-fold excess of a double-
stranded oligodeoxynucleotides containing either a mutated –182/
–176 uPAR AP-1 motif or an irrelevant sequence (SP-1 consensus
binding motif).
Thus, both deletional transcriptional analysis and electrophoretic
mobility shift assays support the involvement of the –182/–176
AP-1 binding site in UVB induction of uPAR gene transcription.
DISCUSSION
UV irradiation has been found to alter the transcription of many
cellular genes via two principal ways (Bender et al, 1997): The
transcription of immediate response genes, e.g., members of the
Jun and Fos families of transcription factors, is increased within
minutes. The as yet earliest detectable cellular reaction to UV is
the modification of cell surface receptors for growth factors, e.g.,
the EGF receptor. This leads, via a cascade of subsequent enzymatic
phosphorylation events, to the activation of preformed transcription
factors which then activate the transcription of early response genes.
The activation of late response genes several hours later appears to
Figure 4. UVB irradiation does not increase uPAR mRNA stability.
Subconfluent cultures of A431 cells were either left untreated, UVB
irradiated (15 mJ per cm2) or stimulated with EGF (10 ng per ml) or PMA
(100 ng per ml). Actinomycin D (10 mg per ml) was added to controls,
to UVB-treated cells 12 h postirradiation and to EGF-treated or PMA-
treated cells after a 12 h incubation period. Total cellular RNA was isolated
after various periods of actinomycin D incubation. Seventeen micrograms
of total RNA were electrophoresed and analyzed by northern blot
hybridization using a 32P-labeled human uPAR cDNA probe and a 32P-
labeled human 28S rRNA oligodeoxynucleotide probe as a control
for loading uniformity. Specific signals on autoradiographic films were
densitometrically quantitated as described in Materials and Methods. The
data are representative of two independent experiments.
depend on UV-induced DNA damage in transcribed regions
and might subsequently involve the synthesis and secretion of
transcription factors and growth factors; e.g., the induction of
the late UV-response gene uPA has been shown to depend on the
synthesis and secretion of a factor that probably acts in an autocrine
fashion (Rotem et al, 1987).
We report the induction of uPA and uPAR expression by UVB
in the keratinocyte cell line A431. Whereas uPA induction has
been reported for UVC in other cell types (Rotem et al, 1987;
Auer et al, 1994; Miralles et al, 1998) our data extend the
documentation of UV inducibility of uPA to UV wavelengths
encountered in the environment and to the cell type that is most
exposed to environmental UV.
This is the first study demonstrating UV inducibility of uPAR.
We found uPAR mRNA induction by UVB to be independent
of protein synthesis. Cycloheximide treatment not only failed to
inhibit UVB induction of uPAR mRNA, but rather increased
uPAR mRNA levels both in untreated and UVB-irradiated A431
cells. Cycloheximide has been previously shown to increase uPAR
mRNA levels in A549 and U937 cells (Lund et al, 1991a,b) and
probably acts by inhibiting the synthesis of a protein that binds and
destabilizes uPAR mRNA. Shortage of the uPAR mRNA binding
protein results in increased mRNA stability (Shetty et al, 1997).
Cycloheximide could also act via the inhibition of the synthesis of
a labile transcriptional repressor.
Both transcriptional and post-transcriptional mechanisms have
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Figure 5. UVB increases uPAR promoter activity and mutation of the –182/–176 AP-1 binding site abolishes UVB inducibility.
(A) Schematic depiction of uPAR-based CAT reporter gene constructs. The largest incorporated genomic uPAR fragment contains 398 bp of 59
flanking region, the transcription start site (marked by a bent arrow), and the first 51 transcribed base positions. Additionally, 59 deletion mutants
are designated according to the most 59 nucleotide position incorporated. In the –398∆AP-1 CAT construct the AP-1 transcription factor binding
sequence is mutated as described in Materials and Methods. A CAT plasmid devoid of uPAR sequences, but otherwise identical to the –398 uPAR
construct (pSV0-CAT) is used as a negative control. X, XbaI restriction site. (B) Subconfluent cell cultures were transiently transfected with the
–398/151 uPAR-promoter CAT construct (uPAR) or a promoter-less CAT construct (pSV0-CAT) as described in Materials and Methods. Transfected
cells were left untreated or UVB irradiated (15 mJ per cm2) and lysed 24 h postirradidation. Autoradiograph of a thin-layer chromatography of
CAT reporter assays. CM, 14C-chloramphenicol substrate; 1-Ac-CM and 3-Ac-CM, monoacetylated products. (C) CAT plasmids containing various
portions of the uPAR promoter or the –398∆AP-1 CAT construct were transiently transfected into A431 cells, which were either left untreated
or exposed to UVB (15 mJ per cm2). Cell lysates were prepared 24 h postirradiation. Promoter inducibility is expressed as the ratio of CAT
concentration of lysates from irradiated transfectants divided by the CAT concentration of lysates from untreated transfectants. Inducibility ratio
(CAT induction factor) is depicted as mean 6 SD from five independent experiments.
been identified in the regulation of uPAR expression by various
cytokines, growth factors, or pharmacologic stimuli. Whereas
transcriptional activation prevails in the uPAR induction by cyclic
adenosine monophosphate or EGF, other stimuli such as trans-
forming growth factor-β and PMA appear to act both at the
transcriptional and post-transcriptional levels (Lund et al, 1995;
Niiya et al, 1998). Post-transcriptional mechanisms mediate the
induction of uPAR mRNA by cycloheximide (Shetty et al, 1997)
and uPAR induction in response to LFA-1/CD3 costimulation in
the T cell line Jurkat (Wang et al, 1998). UVB appears to
induce uPAR transcriptionally as demonstrated by our transfection
experiments with uPAR-promoter/CAT constructs, whereas studies
of mRNA stability did not yield any indication for an influence of
UVB on uPAR mRNA stability. Therefore, transcriptional induc-
tion probably fully accounts for the observed increase of uPAR
mRNA and surface expression in response to UVB.
In uPAR-promoter constructs transiently transfected into A431
cells UVB irradiation resulted in a transcriptional activation, and
mutation of the –182/–176 AP-1 binding site nearly abolished
UVB response. AP-1 is an important mediator of cellular UV
responses and is activated by enzymatic phosphorylation of its
constituents, e.g., c-Fos or c-Jun. This phosphorylation can be
achieved by UV activation of several protein kinases (c-Jun N-
terminal kinases, p38 mitogen-activated protein kinases, or extra-
cellular signal-regulated kinases) (Hibi et al, 1993; Price et al, 1996)
and results in transcriptional activation of AP-1 regulated promoters
(Bender et al, 1997). The same –182/–176 AP-1 site has recently
be shown to be essential for the transcriptional activation of uPAR
by PMA in colon and ovarian cancer cell lines (Lengyel et al, 1996;
Gum et al, 1998). Other putative transcription factor binding sites
have been localized within the investigated portion of the uPAR
promoter (Casey et al, 1994; Soravia et al, 1995; Wang et al, 1995).
There are several SP-1 binding sites that appear to contribute to
uPAR promoter activity according to transfection experiments
(Soravia et al, 1995). Additionally, binding motifs for AP-2 (–168/
–161) and PEA (–248/–241) have been identified; however, to
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Figure 6. UVB increases binding activity at the –182/–176 AP-1
binding site of the uPAR promoter. Nuclear extracts were
prepared from A431 cells that were UVB irradiated (15 mJ per cm2)
at various hours prior to extraction. Unirradiated controls were taken out
of the incubator at each irradiation time-point for the time of irradiation.
Extracts were incubated with a digoxigenin-labeled double-stranded
oligodeoxynucleotide probe representing genomic uPAR sequence
including the AP-1 binding motif 59 TGAGTCA (positions –182/–176
relative to the transcription start site). DNA–protein binding complexes
were resolved by electrophoresis on a nondenaturing 6% polyacrylamide
gel. The data are representative of three independent experiments.
Competition studies were performed by adding to the reactions a 100-
fold excess of unlabeled identical double-stranded oligodeoxynucleotide
probe (UP); a double-stranded oligodeoxynucleotide of irrelevant
sequence (SP-1), a double-stranded oligodeoxynucleotide containing an
AP-1 consensus-binding sequence (AP-1 consensus); a double-stranded
oligodeoxynucleotide containing a mutated –182/–176 uPAR AP-1
binding site (mAP-1 uPAR); or an AP-1 binding sequence derived
from the uPA promoter (AP-1 uPA). Specific binding complexes are
marked by an arrow.
date no functional data to their relevance for uPAR promoter
activity have been published. As deletion or mutation of the AP-1
site almost, but not totally, abolished UVB inducibility, it cannot
be excluded that additional transcription factor binding sites make
minor contributions to the UVB induction of the uPAR promoter.
UVB-induced binding at the uPAR AP-1 motif was delayed and
was not observed 90 min postirradiation, although the UV induction
of AP-1 activity is usually more rapid starting within 1 h postirradi-
ation (Stein et al, 1989; Devary et al, 1991). Furthermore, the induc-
tion kinetics of uPAR mRNA by UVB irradiation were slow and
sustained with maximal induction 24 h postirradiation (Fig 2A). This
is different from the faster induction by several other stimuli such as
EGF (Fig 2B) (Lund et al, 1995), interleukin-1β, tumor necrosing
factor-α (Bechtel et al, 1996), or transforming growth factor-β
(Lund et al, 1991b) with a maximal uPAR mRNA increase within
the first 4 h of stimulation. The exact mechanisms responsible for
the observed delayed kinetics are presently unclear. In late UV-
response genes including uPA (Rotem et al, 1987) the synthesis of
transcription factors or growth factors is required for UV induction,
which could explain the delayed response. Our cycloheximide
experiments, however, suggest that no protein synthesis is required
for the UVB induction of uPAR. As another possible mechanism
contributing to a delayed response, mRNA stabilization by UV has
recently been documented in the c-fos gene 4–10 h postirradiation
(Bender et al, 1997), but this is not likely to be relevant for uPAR
according to the actinomycin D incubation experiments.
The binding of autoantibodies to desmosomal antigens is gener-
ally regarded the primary pathogenic event leading to acantholysis
and epidermal blisters (Amagai, 1996). Targeted gene disruption of
such a desmosomal antigen, murine desmoglein 3, causes mucosal
lesions that are phenotypically similar to pemphigus vulgaris (Koch
et al, 1997). Still there is evidence as outlined in the introduction
that the uPA/plasminogen system may be activated subsequent to
antibody binding and act as an effector system enhancing acantho-
lysis. As UVB induces uPA and uPAR expression in vitro, it is
tempting to speculate that activation of the uPA/plasminogen
proteolytic system by UV radiation may facilitate photoprovocation
of acantholytic lesions in pemphigus patients. UV-enhanced proteo-
lytic activity, however, may also result from the induction of other
proteases. Of note, besides uPA, tissue-type plasminogen activator
is detected in pemphigus lesions in substantial amounts (Baird et al,
1990; Reinartz et al, 1993) and is also inducible by UV radiation
(Rotem et al, 1987; Boothman et al, 1993). Furthermore, the
synthesis of matrix-metalloproteases like collagenase is UV inducible
(Stein et al, 1989). Still, it is a unique feature of uPA that via
binding to uPAR its proteolytic activity is focused pericellularly in
potential proximity to desmosomes. Along with the in vitro data
demonstrating inhibition of pemphigus-antibody-induced acantho-
lysis by inhibition of urokinase activity (Morioka et al, 1987;
Hashimoto et al, 1989; Naito et al, 1989; Xue et al, 1998), this
makes uPA an attractive candidate for a mediator of UV-aggravated
acantholysis.
Taken together, we have demonstrated that UVB induces the
expression of two components of the proteolytic uPA/plasminogen
system, uPA and uPAR, in an epidermal keratinocyte cell line. The
epidermal induction of components of the urokinase system by
UVB may help explain the mechanisms responsible for the photo-
sensitivity of pemphigus.
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